#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	3720	16S	1529	1529	100.0	16S.l15.c17.ctg.1	2073	299.8	1	SNP	n	C1184T	0	.	.	1184	1184	C	1386	1386	C	403	C	232	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	3720	16S	1529	1529	100.0	16S.l15.c17.ctg.1	2073	299.8	0	HET	.	.	.	G1447A	.	1447	1447	G	1649	1649	G	410	G,A	173,61	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	3720	16S	1529	1529	100.0	16S.l15.c17.ctg.1	2073	299.8	0	HET	.	.	.	A69G	.	69	69	A	271	271	A	332	A,G	142,51	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	6924	23S	2890	2890	99.86	23S.l15.c17.ctg.1	3542	316.0	0	.	n	.	0	T695C	SNP	695	695	T	1134	1134	C	391	C,T	220,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	6924	23S	2890	2890	99.86	23S.l15.c17.ctg.1	3542	316.0	0	.	n	.	0	G1337A	SNP	1337	1337	G	1776	1776	A	302	A,C	175,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	6924	23S	2890	2890	99.86	23S.l15.c17.ctg.1	3542	316.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2410	2410	C	312	C,T	183,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	6924	23S	2890	2890	99.86	23S.l15.c17.ctg.1	3542	316.0	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	3036	3036	T	311	T	185	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	6924	23S	2890	2890	99.86	23S.l15.c17.ctg.1	3542	316.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2484	2484	A	315	A	193	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	6924	23S	2890	2890	99.86	23S.l15.c17.ctg.1	3542	316.0	0	HET	.	.	.	C1346T	.	1346	1346	C	1785	1785	C	297	C,T	99,75	.	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	286	folP	855	855	100.0	folP.l15.c4.ctg.1	1471	32.8	1	SNP	p	R229S	1	.	.	685	687	AGC	1015	1017	AGC	44;44;46	A;G;C	23;24;25	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	539	688	gyrA	2751	2751	99.78	gyrA.l15.c4.ctg.1	3401	34.5	0	.	p	.	0	L770F	NONSYN	2308	2310	TTG	2658	2660	TTT	5;5;4	T;T;T	2;3;1	.	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	539	688	gyrA	2751	2751	99.78	gyrA.l15.c4.ctg.1	3401	34.5	1	SNP	p	S91F	1	.	.	271	273	TTC	621	623	TTC	54;54;54	T;T;C	33;34;34	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	539	688	gyrA	2751	2751	99.78	gyrA.l15.c4.ctg.1	3401	34.5	1	SNP	p	D95G	1	.	.	283	285	GGC	633	635	GGC	62;62;62	G;G;C	37;37;35	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	539	688	gyrA	2751	2751	99.78	gyrA.l15.c4.ctg.1	3401	34.5	1	SNP	p	G95N	0	.	.	283	285	GGC	633	635	GGC	62;62;62	G;G;C	37;37;35	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	27	230	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1157	33.4	1	SNP	p	G45D	0	.	.	133	135	GGC	315	317	GGC	57;57;56	G;G;C	32;32;30	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	136	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	628	32.8	0	.	n	.	0	A197.	DEL	197	197	A	340	340	A	67	A	40	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	678	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2658	44.9	1	SNP	p	D86N	0	.	.	256	258	GAC	400	402	GAC	46;45;47	G;A;C	29;27;30	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	678	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2658	44.9	1	SNP	p	S87R	1	.	.	259	261	CGT	403	405	CGT	47;47;47	C;G;T	30;25;26	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	678	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2658	44.9	1	SNP	p	R87I	0	.	.	259	261	CGT	403	405	CGT	47;47;47	C;G;T	30;25;26	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	678	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2658	44.9	1	SNP	p	R87W	0	.	.	259	261	CGT	403	405	CGT	47;47;47	C;G;T	30;25;26	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	678	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2658	44.9	1	SNP	p	S88P	0	.	.	262	264	TCC	406	408	TCC	47;47;47	T;C;C	29;29;29	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	492	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2281	35.8	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1382	1384	GGC	28;28;28	G;G;C	20;19;16	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	600	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2051	45.5	1	SNP	p	A311V	0	.	.	931	933	GCA	1061	1063	GCA	60;61;59	G;C;A	35;36;36	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	600	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2051	45.5	1	SNP	p	I312M	0	.	.	934	936	ATC	1064	1066	ATC	60;60;60	A;T;C	35;37;36	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	600	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2051	45.5	1	SNP	p	V316T	0	.	.	946	948	GTG	1076	1078	GTG	59;57;57	G;T;G	35;33;34	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	600	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2051	45.5	1	SNP	p	V316P	0	.	.	946	948	GTG	1076	1078	GTG	59;57;57	G;T;G	35;33;34	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	600	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2051	45.5	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1580	1582	ACC	36;36;33	A;C;C	22;22;21	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	600	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2051	45.5	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1634	1636	GCG	32;33;33	G;C;G	18;20;20	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	600	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2051	45.5	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1634	1636	GCG	32;33;33	G;C;G	18;20;20	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	600	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2051	45.5	1	SNP	p	G543S	1	.	.	1627	1629	AGC	1757	1759	AGC	28;28;28	A;G;C	19;19;20	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	600	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2051	45.5	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1766	1768	GGC	27;27;27	G;G;C	19;19;18	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	600	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2051	45.5	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1784	1786	CCG	24;24;24	C;C;G	14;15;15	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	1114	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	2882	58.1	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1451	1453	CCG	53;53;53	C;C;G	30;30;27	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	324	porA	1146	1146	99.91	porA.l6.c4.ctg.1	1573	34.5	0	.	p	.	0	M83fs	FSHIFT	247	247	A	447	447	C	15	C	8	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	474	porB1b	1047	1047	98.95	porB1b.l15.c4.ctg.1	1523	50.7	0	.	p	.	0	N38E	NONSYN	112	114	AAT	299	301	GAA	73;73;73	G;A;A	41;41;40	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	474	porB1b	1047	1047	98.95	porB1b.l15.c4.ctg.1	1523	50.7	0	.	p	.	0	N134D	NONSYN	400	402	AAT	587	589	GAT	68;72;74	G;A;T	42;44;41	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	474	porB1b	1047	1047	98.95	porB1b.l15.c4.ctg.1	1523	50.7	0	.	p	.	0	P175S	NONSYN	523	525	CCA	710	712	TCA	74;76;76	T;C;A	43;45;43	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	474	porB1b	1047	1047	98.95	porB1b.l15.c4.ctg.1	1523	50.7	0	.	p	.	0	A218V	NONSYN	652	654	GCC	839	841	GTC	42;39;39	G;T;C	27;25;28	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	474	porB1b	1047	1047	98.95	porB1b.l15.c4.ctg.1	1523	50.7	0	.	p	.	0	F222S	NONSYN	664	666	TTT	851	853	TCT	40;40;40	T;C;T	24;23;26	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	474	porB1b	1047	1047	98.95	porB1b.l15.c4.ctg.1	1523	50.7	0	.	p	.	0	N260del	DEL	778	778	A	965	965	A	68	A	41	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	474	porB1b	1047	1047	98.95	porB1b.l15.c4.ctg.1	1523	50.7	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1166	1168	GCA	56;56;54	G;C;A	41;39;39	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	474	porB1b	1047	1047	98.95	porB1b.l15.c4.ctg.1	1523	50.7	1	SNP	p	G120K	1	.	.	358	360	AAG	545	547	AAG	64;64;67	A;A,C;G,C	41;38,1;42,1	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	474	porB1b	1047	1047	98.95	porB1b.l15.c4.ctg.1	1523	50.7	1	SNP	p	A121D	1	.	.	361	363	GAC	548	550	GAC	67;67;68	G;A;C	43;41;44	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	474	porB1b	1047	1047	98.95	porB1b.l15.c4.ctg.1	1523	50.7	1	SNP	p	D121N	0	.	.	361	363	GAC	548	550	GAC	67;67;68	G;A;C	43;41;44	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	2024	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4741	70.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	186	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1067	34.1	1	SNP	p	V57M	1	.	.	169	171	ATG	579	581	ATG	64;59;59	A;T;G	40;37;36	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
